Abbvie Pharmaceutical Trading (Shanghai) Co., Ltd.


Contact Info

Business Scope

AbbVie (NYSE: ABBV) is a global, research-based biopharmaceutical company formed on Jan 2nd, 2013 following a separation from Abbott. AbbVie China uses its knowledge and expertise to develop therapies that cover the four therapeutic areas of Immunology, Virology, Nephrology, and Anesthesiology. AbbVie China has also collaborated with medical institutes and regulatory authorities to roll out several clinical studies in hepatitis C, Oncology, Immunology, Neuroscience/Pain and Women’s Health.